Walmart reports $188.8 billion earnings, analysts raise price targets
Walmart reported third-quarter earnings of 65 cents per share, surpassing analyst expectations, with revenue at $188.835 billion, a 5.2% year-over-year increase. Analysts remain optimistic, raising pโฆ
Walmart Inc. shares are seeing a rebound on Friday after a slight dip the previous day, following the retail giant's third-quarter earnings report. The company announced an adjusted earnings per share (EPS) of 65 cents, which surpassed analyst expectations of 64 cents. This figure excludes a 3-cent per share after-tax loss linked to equity and other investments. Additionally, Walmart reported revenue of $188.835 billion, reflecting a 5.2% year-over-year increase and exceeding the consensus estimate of $187.271 billion.
This uptick in Walmart's stock comes amid ongoing challenges in its pharmacy division, particularly a decline in profits from weight-loss drugs, even as prescription volumes rise. The company has benefited from the recent surge in demand for certain medications, but analysts note that this momentum is beginning to wane. The retail landscape is shifting, and Walmart is adapting to changes in consumer behavior and market dynamics as it navigates these headwinds.
Several analysts responded positively to Walmart's quarterly performance, raising their price targets while keeping their ratings intact. Morgan Stanley's Simeon Gutman lifted his price forecast from $125 to $135, maintaining an Overweight rating. Similarly, Piper Sandler's Peter Keith increased his target from $128 to $138, also keeping an Overweight rating. These revisions reflect confidence in Walmart's ability to sustain growth despite challenges in certain sectors.
Looking ahead, Walmart's ability to maintain its market position will hinge on how effectively it can adapt to evolving trends in retail and healthcare. The company's success in managing pharmacy deflation and capitalizing on its diverse revenue streams will be crucial as it continues to serve a changing consumer base. Analysts will be watching closely to see if Walmart can leverage its strengths to overcome potential setbacks in its pharmacy business.
Read Full Story at Benzinga โ

